The Computer and Technology group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has NVIDIA (NVDA) been one of those stocks this year? Let's take a closer look at the stock's year-to-date performance to find out.NVIDIA is one of 630 individual stocks in the Computer and Technology sector. Collectively, these companies sit at #14 in the Zacks Sector Rank. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. NVDA is currently sporting a Zacks Rank of #1 (Strong Buy).Within the past quarter, the Zacks Consensus Estimate for NVDA's full-year earnings has moved 25.64% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.Based on the most recent data, NVDA has returned 42.57% so far this year. In comparison, Computer and Technology companies have returned an average of 17.23%. This shows that NVIDIA is outperforming its peers so far this year.Breaking things down more, NVDA is a member of the Semiconductor - General industry, which includes 8 individual companies and currently sits at #30 in the Zacks Industry Rank. On average, stocks in this group have lost 22.22% this year, meaning that NVDA is performing better in terms of year-to-date returns.Investors with an interest in Computer and Technology stocks should continue to track NVDA. The stock will be looking to continue its solid performance. Breakout Biotech Stocks with Triple-Digit Profit Potential The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases. Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.See these 7 breakthrough stocks now>>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report NVIDIA Corporation (NVDA): Free Stock Analysis Report To read this article on Zacks.com click here.